We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+12.97%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.39B
AUM Growth
+$49.7M
Cap. Flow
-$131M
Cap. Flow %
-9.44%
Top 10 Hldgs %
39.87%
Holding
313
New
14
Increased
31
Reduced
35
Closed
146

Top Buys

Rank Stock Value
1
VST icon
Vistra
VST
+$28.6M
2
FLG
Flagstar Bank National Association
FLG
+$26.3M
3
BWA icon
BorgWarner
BWA
+$18.4M
4
CLF icon
Cleveland-Cliffs
CLF
+$11.9M
5
VAL icon
Valaris
VAL
+$10.5M

Top Sells

Rank Stock Value
1
GCTS
GCT Semiconductor Holding
GCTS
+$21.6M
2
LITT
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
+$20.3M
3
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$19.9M
4
JPM icon
JPMorgan Chase
JPM
+$19.2M
5
ENVA icon
Enova International
ENVA
+$18.4M

Sector Composition

Rank Sector Weight
1 Financials 18.62%
2 Healthcare 14.45%
3 Consumer Discretionary 11.24%
4 Materials 6.21%
5 Energy 5.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QIPT
226
DELISTED
Quipt Home Medical
QIPT
– –
-29,000
Closed -$203K
RNGR icon
227
Ranger Energy Services
RNGR
$379M
– –
-16,563
Closed -$169K
SCPH
228
DELISTED
scPharmaceuticals
SCPH
– –
-21,000
Closed -$190K
SLND.WS icon
229
Southland Holdings Warrants
SLND.WS
– –
-97,550
Closed -$77.1K
SMHI icon
230
SEACOR Marine Holdings
SMHI
$257M
– –
-18,000
Closed -$137K
SPRY icon
231
ARS Pharmaceuticals
SPRY
$542M
– –
-21,500
Closed -$140K
SRRK icon
232
Scholar Rock
SRRK
$5.49B
– –
-18,000
Closed -$144K
STIM icon
233
Neuronetics
STIM
$150M
– –
-28,157
Closed -$81.9K
SVRA icon
234
Savara
SVRA
$1.11B
– –
-79,000
Closed -$154K
TELA icon
235
TELA Bio
TELA
$33.1M
– –
-16,990
Closed -$181K
TERN
236
DELISTED
Terns Pharmaceuticals
TERN
– –
-16,000
Closed -$189K
TGTX icon
237
TG Therapeutics
TGTX
$7.07B
– –
-775,000
Closed -$11.7M
TRDA icon
238
Entrada Therapeutics
TRDA
$282M
– –
-10,355
Closed -$150K
TUSK icon
239
Mammoth Energy Services
TUSK
$130M
– –
-29,795
Closed -$126K
URGN icon
240
UroGen Pharma
URGN
$1.88B
– –
-19,000
Closed -$176K
VATE icon
241
INNOVATE Corp
VATE
$99.6M
– –
-5,900
Closed -$175K
VIGL
242
DELISTED
Vigil Neuroscience
VIGL
– –
-15,092
Closed -$148K
VMD icon
243
Viemed Healthcare
VMD
$448M
– –
-18,000
Closed -$174K
VOR icon
244
Vor Biopharma
VOR
$1.16B
– –
-1,271
Closed -$137K
VYGR icon
245
Voyager Therapeutics
VYGR
$181M
– –
-23,000
Closed -$177K
WNEB icon
246
Western New England Bancorp
WNEB
$263M
– –
-18,667
Closed -$153K
XAIR icon
247
Beyond Air
XAIR
$4.56M
– –
-72
Closed -$195K
ZVIA icon
248
Zevia
ZVIA
$121M
– –
-45,284
Closed -$174K
CNR
249
Core Natural Resources Inc
CNR
$4.05B
– –
-100,000
Closed -$5.83M
CNR
250
PUT
Core Natural Resources Inc
CNR
$4.05B
– –
-50,000
Closed -$2.91M
8 9
10
11 12

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, 683 Capital Management held 313 positions worth $1.39B, up 3.7% from $1.34B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

683 Capital Management withdrew a net $131M in Q2 2023, closing 146 positions and reducing 35 holdings. Its most notable exit was Logistics Innovation Technologies Corp. Class A Common Stock, an estimated $20.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, 683 Capital Management opened a new position in Vistra worth $30.7M.

  • 683 Capital Management's largest Q2 2023 buy was Vistra: 1,170,000 shares worth $30.7M.
  • 683 Capital Management added most to BorgWarner in Q2 2023, an estimated $18.4M increase.
  • 683 Capital Management's biggest Q2 2023 reduction was GCT Semiconductor Holding, cutting an estimated $21.6M.
  • 683 Capital Management fully exited Logistics Innovation Technologies Corp. Class A Common Stock in Q2 2023, selling an estimated $20.3M.
  • 683 Capital Management's ten largest holdings make up 40% of its $1.39B portfolio in Q2 2023.
  • 683 Capital Management opened 14 new positions and closed 146 in Q2 2023.
  • 683 Capital Management's portfolio value rose 3.7% quarter-over-quarter to $1.39B.

Based on 683 Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.